Showing results (91-100 of 107) with videos related to
Sort By:
Pageof 11
Journal of the American Chemical Society|February 13, 2009
Kinetics of oxidation of benzphetamine by compounds I of cytochrome P450 2B4 and its mutantsXin Sheng, Haoming Zhang, Sang-Choul Im, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 9, 2012
Interactions between CYP2E1 and CYP2B4: effects on affinity for NADPH-cytochrome P450 reductase and substrate metabolismCesar Kenaan, Erin V Shea, Hsia-lien Lin, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 3, 2006
Synthesis of substituted phenyl diaziridines and characterization as mechanism-based inactivators of human cytochrome P450 2B6Chitra Sridar, Yoshimasa Kobayashi, Holly Brevig, et al.Journal of the American Chemical Society|June 13, 2002
Evaluation of norcarane as a probe for radicals in cytochome p450- and soluble methane monooxygenase-catalyzed hydroxylation reactionsMartin Newcomb, Runnan Shen, Yun Lu, et al.Biochimica Et Biophysica Acta|February 16, 2010
Beta sheet 2-alpha helix C loop of cytochrome P450 reductase serves as a docking site for redox partnersHyun-Hee Jang, Arvind P Jamakhandi, Shane Z Sullivan, et al.Biochemistry|December 8, 2005
Regulation of cytochrome P450 2E1 by heat shock protein 90-dependent stabilization and CHIP-dependent proteasomal degradationYoshihiro Morishima, Hwei-Ming Peng, Hsia-lien Lin, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 26, 2006
Structure-activity relationship and elucidation of the determinant factor(s) responsible for the mechanism-based inactivation of cytochrome P450 2B6 by substituted phenyl diaziridinesYoshimasa Kobayashi, Chitra Sridar, Ute M Kent, et al.The Journal of Pharmacology and Experimental Therapeutics|August 12, 2016
Significant Improvement of Antithrombotic Responses to Clopidogrel by Use of a Novel Conjugate as Revealed in an Arterial Model of ThrombosisHaoming Zhang, D Adam Lauver, Hui Wang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 28, 2003
Cytochrome P450 CYP3A4/5 expression as a biomarker of outcome in osteosarcomaHassan R Dhaini, Dafydd G Thomas, Thomas J Giordano, et al.Biochemistry|January 2, 2013
Potent mechanism-based inactivation of cytochrome P450 2B4 by 9-ethynylphenanthrene: implications for allosteric modulation of cytochrome P450 catalysisHaoming Zhang, Sean C Gay, Manish Shah, et al.Pageof 11